M.R. Orazov¹, V.E. Radzinskiy¹, F.F. Minnullina²

 ¹Peoples’ Friendship University of Russia, Moscow

²Kazan (Volga) Federal University, Kazan

 Contact details:

Minnullina F.F. — PhD (Medicine), Associate Professor, Head of the Department of Obstetrics and Gynecology at the Institute of Fundamental Medicine and Biology

Address: 18 Kremlevskaya St., 420008 Kazan, Russian Federation, tel.: +7-987-233-04-78, e-mail: minnullina_f@mail.ru

The incidence of pelvic organ prolapse (POP) in women is increasing worldwide, and experts predict that the trend will continue until 2050. The only available and effective treatment for POP is surgical correction, but it is associated with a high recurrence rate and the need for reoperation. Since it is not feasible to reduce the primary POP incidence, efforts should be directed at preventing recurrence in women with pre-existing dysfunction treated for POP. The outcome of POP surgical correction may depend on both medical tactics and clinical and anamnestic risk factors for POP recurrence.

The purpose — to analyze the data on clinical and anamnestic risk factors reliably associated with recurrent pelvic organ prolapse.

Material and methods. We analyzed the results of scientific papers published and posted in the Cochrane Library, PubMed, ELibrary, and Science Direct electronic libraries between 2014 and 2024 using the keywords: pelvic organ prolapse, risk factors, recurrence.

Conclusions. Based on the analysis, it should be noted that the available understanding of risk factors for POP recurrence is extremely insufficient and contradictory. Identification of significant risk factors of POP recurrence will allow improving preoperative preparation, choice of optimal surgical technique and further management of patients.

Key words: pelvic organ prolapse, pelvic floor muscle dysfunction, recurrence, risk factors, surgical treatment.

REFERENCES

1. Klinicheskie rekomendatsii “Vypadenie zhenskikh polovykh organov” [Clinical guidelines «Prolapse of female genital organs»]. Moscow, 2021. P. 47.
2. Wu J.M., Matthews C.A., Conover M.M. et al. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet. Gynecol, 2014, vol. 123 (6), pp. 1201–1206.
3. Weintraub A.Y., Glinter H., Marcus-Braun N. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse. Int. Braz. J. Urol,2020, vol. 46 (1), pp. 5–14.
4. Bohlin K.S., Ankardal M., Nüssler E. et al. Factors influencing the outcome of surgery for pelvic organ prolapse. Int. Urogynecol. J, 2018, vol. 29 (1), pp. 81–89.
5. Dieter A.A., Wilkins M.F., Wu J.M. Epidemiological trends and future care needs for pelvic floor disorders. Curr. Opin. Obstet. Gynecol, 2015, vol. 27 (5), pp. 380–384.
6. Fritel X., Varnoux N., Zins M. et al. Symptomatic pelvic organ prolapse at midlife, quality of life, and risk factors. Obstet. Gynecol, 2009, vol. 113 (3), pp. 609–616. DOI: 10.1097/AOG.0b013e3181985312
7. Vergeldt T.F., Weemhoff M., IntHout J., Kluivers K.B. Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int. Urogynecol. J, 2015, vol. 26 (11), pp. 1559–1573. DOI: 10.1007/s00192-015-2695-8
8. Bola R., Guo M., Karimuddin A. et al. An examination of rectal prolapse surgery patients’ quality of life and symptoms using patient-reported outcome instruments: A prospective cohort study. Am. J. Surg, 2024, vol. 231, pp. 113–119.
9. Friedman T., Eslick G.D., Dietz H.P. Risk factors for prolapse recurrence: systematic review and meta-analysis. Int. Urogynecol. J, 2018, vol. 29 (1), pp. 13–21. DOI: 10.1007/s00192-017-3475-4
10. Shi W., Guo L. Risk factors for the recurrence of pelvic organ prolapse: a meta-analysis. J. Obstet. Gynaecol, 2023, vol. 43 (1), 2160929.
11. Diez-Itza I., Avila M., Uranga S. et al. Factors involved in prolapse recurrence one year after anterior vaginal repair. Int. Urogynecol. J, 2020, vol. 31 (10), pp. 2027–2034.
12. Yeung E., Malacova E., Maher C. Is levator ani avulsion a risk factor for prolapse recurrence? A systematic review and meta-analysis. Int. Urogynecol. J, 2022, vol. 33 (7), pp. 1813–1826.
13. Schulten S.F.M., Claas-Quax M.J., Weemhoff M. et al. Risk factors for primary pelvic organ prolapse and prolapse recurrence: an updated systematic review and meta-analysis. Am. J. Obstet. Gynecol, 2022, vol. 227 (2), pp. 192–208. DOI: 10.1016/j.ajog.2022.04.046
14. Vergeldt T.F., Notten K.J., Weemhoff M. et al. Levator hiatal area as a risk factor for cystocele recurrence after surgery: a prospective study. BJOG, 2015, vol. 122 (8), pp. 1130–1137. DOI: 10.1111/1471-0528.13340
15. Alcalay M., Stav K., Eisenberg V.H. Family history associated with pelvic organ prolapse in young women. Int. Urogynecol. J, 2015, vol. 26 (12), pp. 1773–1776.
16. Veit-Rubin N., Cartwright R., Singh A.U. et al. Association between joint hypermobility and pelvic organ prolapse in women: a systematic review and meta-analysis. Int. Urogynecol. J, 2016, vol. 27 (10), pp. 1469–1478.
17. Cattani L., Decoene J., Page A.S. et al. Pregnancy, labour and delivery as risk factors for pelvic organ prolapse: a systematic review. Int. Urogynecol. J, 2021, vol. 32 (7), pp. 1623–1631. DOI: 10.1007/s00192-021-04724-y
18. Vergeldt T.F., van Kuijk S.M., Notten K.J. et al. anatomical cystocele recurrence: development and internal validation of a prediction model. Obstet. Gynecol, 2016, vol. 127 (2), pp. 341–347. DOI: 10.1097/AOG.0000000000001272
19. Manodoro S., Frigerio M., Cola A., Spelzini F., Milani R. Risk factors for recurrence after hysterectomy plus native-tissue repair as primary treatment for genital prolapse. Int. Urogynecol. J, 2018, vol. 29 (1), pp. 145–151. DOI: 10.1007/s00192-017-3448-7
20. Wong V., Shek K.L., Goh J. et al. Cystocele recurrence after anterior colporrhaphy with and without mesh use. Eur. J. Obstet. Gynecol. Reprod. Biol, 2014, vol. 172, pp. 131–135.